The Drug Delivery to the Lungs conference (DDL) is the premier conference and industry exhibition which is dedicated to pulmonary and nasal drug delivery.
Author profile
Philip Canner
Head of Drug Delivery
With over twenty years’ experience in medical device leadership, engineering, and management consultancy, Philip has led the development of an extensive range of medical technologies, with a particular focus on drug delivery.
My insights
Design the therapy: Insights from our 2026 Drug Delivery Innovation Summit
Explore insights from our 2026 Drug Delivery Innovation Summit on drug delivery devices, connected care, patient experience and therapy design.
RDD (Respiratory Drug Delivery) 2026
This is the latest Respiratory Drug Delivery conference in a series that has run continuously since 1988 and garnered a sustained reputation for excellent content covering all aspects of drug delivery to the lungs and nose.